Andrew Sleight
12Patents
6h-index
14Co-inventors
59Inventor score
Filing activity: Jun 4, 1997 → Mar 31, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6593472B2 | NK-1 receptor active amine oxide prodrugs | Chemistry; Metallurgy | 53 | Expired |
| US6849624B2 | Aromatic and heteroaromatic substituted amides | Human Necessities | 12 | Expired |
| US6747026B2 | NK-1 receptor active amine oxide prodrugs | Chemistry; Metallurgy | 11 | Expired |
| US6806370B2 | NK-1 receptor active amine oxide prodrugs | Chemistry; Metallurgy | 11 | Expired |
| US6391873B1 | Imidazodiazepine derivative | Human Necessities | 9 | Expired |
| US5932599A | Use of sulfonamides | Chemistry; Metallurgy | 8 | Expired |
| US7939533B2 | Dual NK1/NK3 receptor antagonists | Chemistry; Metallurgy | 3 | Active |
| US6030976A | Use of sulfonamides | Chemistry; Metallurgy | 3 | Expired |
| US5939451A | Use of sulfonamides | Chemistry; Metallurgy | 2 | Expired |
| US5998665A | Use of sulfonamides | Chemistry; Metallurgy | 0 | Expired |
| US6897226B2 | NK-1 receptor active amine oxide prodrugs | Chemistry; Metallurgy | 0 | Expired |
| US8404708B2 | Dual NK1/NK3 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.